TransEnterix Message Board

TransEnterix Senhance robotic sales in U.S.

2 weeks ago

I worked for the company as a contractor for almost a year and can honestly say that this article sums it up very well and is accurate:

TRXC Stock

2 weeks ago

.75 cents and going to 0....

Time to hire more sales reps

4 weeks ago

15 sales reps to compete against Intuitive is a absolute joke.

FDA Grants Fast Track Designation for FARXIGA in Heart Failure

13 hours ago

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).

Will TransEnterix get Acquired?

2 months ago

TRXC may need to get acquired soon. They are in asset sale mode selling AutoLap -

The total proceeds to be paid to the Company for the AutoLap product and intellectual property assets is $17 million, payable in the amount of $5 million by July 31, 2019 and $12 million by November 30, 2019. In addition, GBIL is making an equity investment of $30.0 million in TransEnterix common stock at $2.00 per share, payable on or before September 30, 2019. As a part of the sale agreement, the Company retains o…

Intact Vascular to Announce One-Year Data from TOBA III Clinical Trial

13 hours ago

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year data from its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial will be presented during the High Impact Clinical Research session of the 31st

Senhance Sales 2018 and 2019

4 months ago

And now only 48M left in the bank, which is just enough capital to get them through 2020....

Senhance Having Quality Issues

5 months ago

It shouldn't be hard to figure out but I'll give ya a freebie: Florida Hospital

White Diamond Research

6 months ago

The only thing that is Junk is White Diamond's slander of a good up and coming company. Is a half truth still a Lie? Shorts like to feed just enough truth that they can convince... but in the end its still nothing more than a lie. This company is slowly making a lot of first in the industry. They are selling systems in the US and across the world. This small company is making sound changes in the market. The market has been dominated by one company for a long time... of course it will take time …

National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

14 hours ago

​Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that the National Lipid Association (NLA) has issued a position statement recognizing the cardiovascular risk-lowering effects of icosapent ethyl based on the landmark REDUCE-IT cardiovascular outcomes study.

TransEnterix Senhance Sold at Pascack Valley Medical Center

6 months ago

sure. and what's the "discount" price relative to the "real" price? why not post the info from the 10K to back up your statement?

TRXC Insider Selling

7 months ago

Slattery looks like a genius after that quarterly performance.

Celgene Announces Phase 3 QUAZAR AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

3 days ago

Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001. The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML)

The Biggest Competition for TransEnterix is JNJ and Medtronic

7 months ago

To the OP, thanks for sharing these quotes. Here is our follow up-